Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
710
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
August 16, 2021
0Primary Completion Date
July 6, 2022
0Study Completion Date
July 6, 2022
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Drug0
Intervention Name
LY34718510
Interventional Trial Phase
Phase 10
Official Name
A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Healthy Participants0
Last Updated
November 18, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary
The main purpose of this study is to estimate how much LY3471851 gets into the blood stream and how long it takes the body to remove it when administered under the skin in healthy participants. The study will also evaluate the safety and tolerability of LY3471851. The study is expected to last up to 87 days for each participant.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
